메뉴 건너뛰기




Volumn 61, Issue 3, 2014, Pages 515-522

The role of hepatitis B surface antigen quantification in predicting HBsAg loss and HBV relapse after discontinuation of lamivudine treatment

Author keywords

HBeAg seroconversion; HBV relapse; Hepatitis B surface antigen; Hepatitis B virus

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; ANTIVIRUS AGENT; BIOLOGICAL MARKER;

EID: 84906318814     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.04.029     Document Type: Article
Times cited : (144)

References (36)
  • 1
    • 0030707941 scopus 로고    scopus 로고
    • Hepatitis B virus infection
    • W.M. Lee Hepatitis B virus infection N Engl J Med 337 1997 1733 1745
    • (1997) N Engl J Med , vol.337 , pp. 1733-1745
    • Lee, W.M.1
  • 2
    • 0027422748 scopus 로고
    • From hepatitis to hepatoma: Lessons from type B viral hepatitis
    • D.S. Chen From hepatitis to hepatoma: lessons from type B viral hepatitis Science 262 1993 369 370
    • (1993) Science , vol.262 , pp. 369-370
    • Chen, D.S.1
  • 3
    • 59149086601 scopus 로고    scopus 로고
    • Natural history of chronic hepatitis B virus infection and long-term outcome under treatment
    • Y.F. Liaw Natural history of chronic hepatitis B virus infection and long-term outcome under treatment Liver Int 29 2009 100 107
    • (2009) Liver Int , vol.29 , pp. 100-107
    • Liaw, Y.F.1
  • 4
    • 0033214863 scopus 로고    scopus 로고
    • Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection
    • C.M. Lee, S.N. Lu, C.S. Changchien, C.T. Yeh, T.T. Hsu, and J.H. Tang et al. Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection Cancer 86 1999 1143 1150
    • (1999) Cancer , vol.86 , pp. 1143-1150
    • Lee, C.M.1    Lu, S.N.2    Changchien, C.S.3    Yeh, C.T.4    Hsu, T.T.5    Tang, J.H.6
  • 5
    • 0033797827 scopus 로고    scopus 로고
    • Hepatitis B e antigen seroconversion after lamivudine therapy is not durable in patients with chronic hepatitis B in Korea
    • B.C. Song, D.J. Suh, H.C. Lee, Y.H. Chung, and Y.S. Lee Hepatitis B e antigen seroconversion after lamivudine therapy is not durable in patients with chronic hepatitis B in Korea Hepatology 32 2000 803 806
    • (2000) Hepatology , vol.32 , pp. 803-806
    • Song, B.C.1    Suh, D.J.2    Lee, H.C.3    Chung, Y.H.4    Lee, Y.S.5
  • 6
    • 0036844794 scopus 로고    scopus 로고
    • Durability of lamivudine-induced HBeAg seroconversion for chronic hepatitis B patients with acute exacerbation
    • C.M. Lee, G.Y. Ong, S.N. Lu, J.H. Wang, C.A. Liao, and H.D. Tung et al. Durability of lamivudine-induced HBeAg seroconversion for chronic hepatitis B patients with acute exacerbation J Hepatol 37 2002 669 674
    • (2002) J Hepatol , vol.37 , pp. 669-674
    • Lee, C.M.1    Ong, G.Y.2    Lu, S.N.3    Wang, J.H.4    Liao, C.A.5    Tung, H.D.6
  • 7
    • 84984538817 scopus 로고    scopus 로고
    • Chronic hepatitis B: Whom to treat and for how long? Proposition, challenges, and future directions
    • S.H. Ahn, H.L. Chan, P.J. Chen, J. Cheng, M.K. Goenka, and J. Hou et al. Chronic hepatitis B: whom to treat and for how long? Proposition, challenges, and future directions Hepatol Int 4 2010 386 395
    • (2010) Hepatol Int , vol.4 , pp. 386-395
    • Ahn, S.H.1    Chan, H.L.2    Chen, P.J.3    Cheng, J.4    Goenka, M.K.5    Hou, J.6
  • 8
    • 0037371186 scopus 로고    scopus 로고
    • Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: Relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase
    • A.B. van Nunen, B.E. Hansen, D.J. Suh, H.F. Löhr, L. Chemello, and H. Fontaine et al. Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase Gut 52 2003 420 424
    • (2003) Gut , vol.52 , pp. 420-424
    • Van Nunen, A.B.1    Hansen, B.E.2    Suh, D.J.3    Löhr, H.F.4    Chemello, L.5    Fontaine, H.6
  • 9
    • 51049107683 scopus 로고    scopus 로고
    • Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2008 update
    • Y.F. Liaw, N.W. Leung, J.H. Kao, R. Guan, D.I. Tai, and K.Y. Ng et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update Hepatol Int 2 2008 263 283
    • (2008) Hepatol Int , vol.2 , pp. 263-283
    • Liaw, Y.F.1    Leung, N.W.2    Kao, J.H.3    Guan, R.4    Tai, D.I.5    Ng, K.Y.6
  • 10
    • 66049153294 scopus 로고    scopus 로고
    • Withdrawal of lamivudine in HBeAg-positive chronic hepatitis B patients after achieving effective maintained virological suppression
    • C.T. Yeh, C.W. Hsu, Y.C. Chen, and Y.F. Liaw Withdrawal of lamivudine in HBeAg-positive chronic hepatitis B patients after achieving effective maintained virological suppression J Clin Virol 45 2009 114 118
    • (2009) J Clin Virol , vol.45 , pp. 114-118
    • Yeh, C.T.1    Hsu, C.W.2    Chen, Y.C.3    Liaw, Y.F.4
  • 11
    • 68349128691 scopus 로고    scopus 로고
    • The duration of lamivudine therapy for chronic hepatitis B: Cessation vs. Continuation of treatment after HBeAg seroconversion
    • J. Fung, C.L. Lai, Y. Tanaka, M. Mizokami, J. Yuen, and D.K. Wong et al. The duration of lamivudine therapy for chronic hepatitis B: cessation vs. continuation of treatment after HBeAg seroconversion Am J Gastroenterol 104 2009 1940 1946
    • (2009) Am J Gastroenterol , vol.104 , pp. 1940-1946
    • Fung, J.1    Lai, C.L.2    Tanaka, Y.3    Mizokami, M.4    Yuen, J.5    Wong, D.K.6
  • 12
    • 8444233579 scopus 로고    scopus 로고
    • Correlation of quantitative assay of hepatitis B surface antigen and HBV DNA levels in asymptomatic hepatitis B virus carriers
    • C.H. Chen, C.M. Lee, J.H. Wang, H.D. Tung, C.H. Hung, and S.N. Lu Correlation of quantitative assay of hepatitis B surface antigen and HBV DNA levels in asymptomatic hepatitis B virus carriers Eur J Gastroenterol Hepatol 16 2004 1213 1218
    • (2004) Eur J Gastroenterol Hepatol , vol.16 , pp. 1213-1218
    • Chen, C.H.1    Lee, C.M.2    Wang, J.H.3    Tung, H.D.4    Hung, C.H.5    Lu, S.N.6
  • 13
    • 2942532722 scopus 로고    scopus 로고
    • Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy
    • B. Werle-Lapostolle, S. Bowden, S. Locarnini, K. Wursthorn, J. Petersen, and G. Lau et al. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy Gastroenterology 126 2004 1750 1758
    • (2004) Gastroenterology , vol.126 , pp. 1750-1758
    • Werle-Lapostolle, B.1    Bowden, S.2    Locarnini, S.3    Wursthorn, K.4    Petersen, J.5    Lau, G.6
  • 14
    • 77952716572 scopus 로고    scopus 로고
    • Serum hepatitis B surface antigen and hepatitis B e antigen titers: Disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers
    • A.J. Thompson, T. Nguyen, D. Iser, A. Ayres, K. Jackson, and M. Littlejohn et al. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers Hepatology 51 2010 1933 1944
    • (2010) Hepatology , vol.51 , pp. 1933-1944
    • Thompson, A.J.1    Nguyen, T.2    Iser, D.3    Ayres, A.4    Jackson, K.5    Littlejohn, M.6
  • 15
    • 77950594817 scopus 로고    scopus 로고
    • On-treatment serum HBsAg level is predictive of sustained off-treatment virologic response to telbivudine in HBeAg-positive chronic hepatitis B patients
    • W. Cai, Q. Xie, B. An, H. Wang, X. Zhou, and G. Zhao et al. On-treatment serum HBsAg level is predictive of sustained off-treatment virologic response to telbivudine in HBeAg-positive chronic hepatitis B patients J Clin Virol 48 2010 22 26
    • (2010) J Clin Virol , vol.48 , pp. 22-26
    • Cai, W.1    Xie, Q.2    An, B.3    Wang, H.4    Zhou, X.5    Zhao, G.6
  • 16
    • 79960013101 scopus 로고    scopus 로고
    • Predictors of relapse in chronic hepatitis B after discontinuation of anti-viral therapy
    • Y. Liang, J. Jiang, M. Su, Z. Liu, W. Guo, and X. Huang et al. Predictors of relapse in chronic hepatitis B after discontinuation of anti-viral therapy Aliment Pharmacol Ther 34 2011 344 352
    • (2011) Aliment Pharmacol Ther , vol.34 , pp. 344-352
    • Liang, Y.1    Jiang, J.2    Su, M.3    Liu, Z.4    Guo, W.5    Huang, X.6
  • 17
    • 83455163799 scopus 로고    scopus 로고
    • Prediction of off-treatment response to lamivudine by serum hepatitis B surface antigen quantification in hepatitis B e antigen-negative patients
    • H.L. Chan, G.L. Wong, A.M. Chim, H.Y. Chan, S.H. Chu, and V.W. Wong Prediction of off-treatment response to lamivudine by serum hepatitis B surface antigen quantification in hepatitis B e antigen-negative patients Antivir Ther 16 2011 1249 1257
    • (2011) Antivir Ther , vol.16 , pp. 1249-1257
    • Chan, H.L.1    Wong, G.L.2    Chim, A.M.3    Chan, H.Y.4    Chu, S.H.5    Wong, V.W.6
  • 18
    • 84865376141 scopus 로고    scopus 로고
    • Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2012 update
    • Y.F. Liaw, J.H. Kao, T. Piratvisuth, H.L.Y. Chan, R.N. Chien, and C.J. Liu et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update Hepatol Int 6 2012 531 561
    • (2012) Hepatol Int , vol.6 , pp. 531-561
    • Liaw, Y.F.1    Kao, J.H.2    Piratvisuth, T.3    Chan, H.L.Y.4    Chien, R.N.5    Liu, C.J.6
  • 19
    • 84865487986 scopus 로고    scopus 로고
    • Sustained responses and loss of HBsAg in HBeAg-negative patients with chronic hepatitis B who stop long-term treatment with adefovir
    • S.J. Hadziyannis, V. Sevastianos, I. Rapti, D. Vassilopoulos, and E. Hadziyannis Sustained responses and loss of HBsAg in HBeAg-negative patients with chronic hepatitis B who stop long-term treatment with adefovir Gastroenterology 143 2012 629 636
    • (2012) Gastroenterology , vol.143 , pp. 629-636
    • Hadziyannis, S.J.1    Sevastianos, V.2    Rapti, I.3    Vassilopoulos, D.4    Hadziyannis, E.5
  • 20
    • 0033045135 scopus 로고    scopus 로고
    • Hepatitis B virus genotype assignment using restriction fragment length polymorphism patterns
    • M. Mizokami, T. Nakano, E. Orito, Y. Tanaka, H. Sakugawa, and M. Mukaide et al. Hepatitis B virus genotype assignment using restriction fragment length polymorphism patterns FEBS Lett 450 1999 66 71
    • (1999) FEBS Lett , vol.450 , pp. 66-71
    • Mizokami, M.1    Nakano, T.2    Orito, E.3    Tanaka, Y.4    Sakugawa, H.5    Mukaide, M.6
  • 21
    • 0037260187 scopus 로고    scopus 로고
    • Prevalence and clinical implications of hepatitis B virus genotypes in southern Taiwan
    • C.M. Lee, C.H. Chen, S.N. Lu, H.D. Tung, W.J. Chou, and J.H. Wang et al. Prevalence and clinical implications of hepatitis B virus genotypes in southern Taiwan Scand J Gastroenterol 1 2003 95 101
    • (2003) Scand J Gastroenterol , vol.1 , pp. 95-101
    • Lee, C.M.1    Chen, C.H.2    Lu, S.N.3    Tung, H.D.4    Chou, W.J.5    Wang, J.H.6
  • 22
    • 0033797827 scopus 로고    scopus 로고
    • Hepatitis B e antigen seroconversion after lamivudine therapy is not durable in patients with chronic hepatitis B in Korea
    • B.C. Song, D.J. Suh, H.C. Lee, Y.H. Chung, and Y.S. Lee Hepatitis B e antigen seroconversion after lamivudine therapy is not durable in patients with chronic hepatitis B in Korea Hepatology 32 2000 803 806
    • (2000) Hepatology , vol.32 , pp. 803-806
    • Song, B.C.1    Suh, D.J.2    Lee, H.C.3    Chung, Y.H.4    Lee, Y.S.5
  • 23
    • 0036844794 scopus 로고    scopus 로고
    • Durability of lamivudine induced HBeAg seroconversion for chronic hepatitis B patients with acute exacerbation
    • C.M. Lee, G.Y. Ong, S.N. Lu, J.H. Wang, C.A. Liao, and H.D. Tung et al. Durability of lamivudine induced HBeAg seroconversion for chronic hepatitis B patients with acute exacerbation J Hepatol 37 2002 669 674
    • (2002) J Hepatol , vol.37 , pp. 669-674
    • Lee, C.M.1    Ong, G.Y.2    Lu, S.N.3    Wang, J.H.4    Liao, C.A.5    Tung, H.D.6
  • 24
    • 0142244873 scopus 로고    scopus 로고
    • Determinants for sustained HBeAg response to lamivudine therapy
    • R.N. Chien, C.T. Yeh, S.L. Tsai, C.M. Chu, and Y.F. Liaw Determinants for sustained HBeAg response to lamivudine therapy Hepatology 38 2003 1267 1273
    • (2003) Hepatology , vol.38 , pp. 1267-1273
    • Chien, R.N.1    Yeh, C.T.2    Tsai, S.L.3    Chu, C.M.4    Liaw, Y.F.5
  • 25
    • 84983726125 scopus 로고    scopus 로고
    • Young chronic hepatitis B patients with nucleos(t)ide analogue-induced hepatitis B e antigen seroconversion have a higher risk of HBV reactivation
    • T.C. Tseng, C.J. Liu, T.H. Su, H.C. Yang, C.C. Wang, and C.L. Chen et al. Young chronic hepatitis B patients with nucleos(t)ide analogue-induced hepatitis B e antigen seroconversion have a higher risk of HBV reactivation J Infect Dis 206 2012 1521 1531
    • (2012) J Infect Dis , vol.206 , pp. 1521-1531
    • Tseng, T.C.1    Liu, C.J.2    Su, T.H.3    Yang, H.C.4    Wang, C.C.5    Chen, C.L.6
  • 26
    • 68349128691 scopus 로고    scopus 로고
    • The duration of lamivudine therapy for chronic hepatitis B: Cessation vs. Continuation of treatment after HBeAg seroconversion
    • J. Fung, C.L. Lai, Y. Tanaka, M. Mizokami, J. Yuen, and D.K. Wong et al. The duration of lamivudine therapy for chronic hepatitis B: cessation vs. continuation of treatment after HBeAg seroconversion Am J Gastroenterol 104 2009 1940 1946
    • (2009) Am J Gastroenterol , vol.104 , pp. 1940-1946
    • Fung, J.1    Lai, C.L.2    Tanaka, Y.3    Mizokami, M.4    Yuen, J.5    Wong, D.K.6
  • 27
    • 75449093009 scopus 로고    scopus 로고
    • Lamivudine maintenance beyond one year after HBeAg seroconversion is a major factor for sustained virologic response in HBeAg-positive chronic hepatitis B
    • H.W. Lee, H.J. Lee, J.S. Hwang, J.H. Sohn, J.Y. Jang, and K.J. Han et al. Lamivudine maintenance beyond one year after HBeAg seroconversion is a major factor for sustained virologic response in HBeAg-positive chronic hepatitis B Hepatology 51 2010 415 421
    • (2010) Hepatology , vol.51 , pp. 415-421
    • Lee, H.W.1    Lee, H.J.2    Hwang, J.S.3    Sohn, J.H.4    Jang, J.Y.5    Han, K.J.6
  • 28
    • 34249090519 scopus 로고    scopus 로고
    • Two-year lamivudine treatment for hepatitis B e antigen-negative chronic hepatitis B: A double-blind, placebo-controlled trial
    • H.L. Chan, H. Wang, J. Niu, A.M. Chim, and J.J. Sung Two-year lamivudine treatment for hepatitis B e antigen-negative chronic hepatitis B: a double-blind, placebo-controlled trial Antivir Ther 12 2007 345 353
    • (2007) Antivir Ther , vol.12 , pp. 345-353
    • Chan, H.L.1    Wang, H.2    Niu, J.3    Chim, A.M.4    Sung, J.J.5
  • 29
    • 79951623871 scopus 로고    scopus 로고
    • Poor durability of lamivudine effectiveness despite stringent cessation criteria: A prospective clinical study in hepatitis B e antigen negative chronic hepatitis B patients
    • F. Liu, L. Wang, X.Y. Li, Y.D. Liu, J.B. Wang, and Z.H. Zhang et al. Poor durability of lamivudine effectiveness despite stringent cessation criteria: a prospective clinical study in hepatitis B e antigen negative chronic hepatitis B patients J Gastroenterol Hepatol 26 2011 456 460
    • (2011) J Gastroenterol Hepatol , vol.26 , pp. 456-460
    • Liu, F.1    Wang, L.2    Li, X.Y.3    Liu, Y.D.4    Wang, J.B.5    Zhang, Z.H.6
  • 30
    • 0036789020 scopus 로고    scopus 로고
    • Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection
    • Y.C. Chen, I.S. Sheen, C.M. Chu, and Y.F. Liaw Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection Gastroenterology 123 2002 1084 1089
    • (2002) Gastroenterology , vol.123 , pp. 1084-1089
    • Chen, Y.C.1    Sheen, I.S.2    Chu, C.M.3    Liaw, Y.F.4
  • 31
    • 2542516261 scopus 로고    scopus 로고
    • HBsAg seroclearance in chronic hepatitis B in the Chinese: Virological, histological, and clinical aspects
    • M.F. Yuen, D.K. Wong, E. Sablon, E. Tse, I.O. Ng, and H.J. Yuan et al. HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects Hepatology 39 2004 1694 1701
    • (2004) Hepatology , vol.39 , pp. 1694-1701
    • Yuen, M.F.1    Wong, D.K.2    Sablon, E.3    Tse, E.4    Ng, I.O.5    Yuan, H.J.6
  • 32
    • 84879843826 scopus 로고    scopus 로고
    • Combining HBsAg decline and HBV DNA levels predict clinical outcomes in patients with spontaneous HBeAg seroconversion
    • S.C. Yang, S.N. Lu, C.M. Lee, T.H. Hu, J.H. Wang, and C.H. Hung et al. Combining HBsAg decline and HBV DNA levels predict clinical outcomes in patients with spontaneous HBeAg seroconversion Hepatol Intern 7 2013 489 499
    • (2013) Hepatol Intern , vol.7 , pp. 489-499
    • Yang, S.C.1    Lu, S.N.2    Lee, C.M.3    Hu, T.H.4    Wang, J.H.5    Hung, C.H.6
  • 33
    • 84984552614 scopus 로고    scopus 로고
    • Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters
    • T.C. Tseng, C.J. Liu, T.H. Su, C.C. Wang, C.L. Chen, and P.J. Chen et al. Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters Gastroenterology 141 2011 517 525
    • (2011) Gastroenterology , vol.141 , pp. 517-525
    • Tseng, T.C.1    Liu, C.J.2    Su, T.H.3    Wang, C.C.4    Chen, C.L.5    Chen, P.J.6
  • 34
    • 84984571825 scopus 로고    scopus 로고
    • Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load
    • T.C. Tseng, C.J. Liu, H.C. Yang, T.H. Su, C.C. Wang, and C.L. Chen et al. Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load Hepatology 55 2012 68 76
    • (2012) Hepatology , vol.55 , pp. 68-76
    • Tseng, T.C.1    Liu, C.J.2    Yang, H.C.3    Su, T.H.4    Wang, C.C.5    Chen, C.L.6
  • 35
    • 84857194778 scopus 로고    scopus 로고
    • Decreasing levels of HBsAg predict HBsAg seroclearance in patients with inactive chronic hepatitis B virus infection
    • Y.C. Chen, W.J. Jeng, C.M. Chu, and Y.F. Liaw Decreasing levels of HBsAg predict HBsAg seroclearance in patients with inactive chronic hepatitis B virus infection Clin Gastroenterol Hepatol 10 2012 297 302
    • (2012) Clin Gastroenterol Hepatol , vol.10 , pp. 297-302
    • Chen, Y.C.1    Jeng, W.J.2    Chu, C.M.3    Liaw, Y.F.4
  • 36
    • 84884319490 scopus 로고    scopus 로고
    • Clearance of hepatitis B surface antigen during long-term nucleot(s)ide analog treatment in chronic hepatitis B: Results from a nine-year longitudinal study
    • T. Hosaka, F. Suzuki, M. Kobayashi, Y. Seko, Y. Kawamura, and H. Sezaki et al. Clearance of hepatitis B surface antigen during long-term nucleot(s)ide analog treatment in chronic hepatitis B: results from a nine-year longitudinal study J Gastroenterol 48 2013 930 941
    • (2013) J Gastroenterol , vol.48 , pp. 930-941
    • Hosaka, T.1    Suzuki, F.2    Kobayashi, M.3    Seko, Y.4    Kawamura, Y.5    Sezaki, H.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.